OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy
Subhajit Chatterjee, Saptarshi Sinha, Chanakya Nath Kundu
European Journal of Pharmacology (2021) Vol. 911, pp. 174516-174516
Closed Access | Times Cited: 60
Subhajit Chatterjee, Saptarshi Sinha, Chanakya Nath Kundu
European Journal of Pharmacology (2021) Vol. 911, pp. 174516-174516
Closed Access | Times Cited: 60
Showing 1-25 of 60 citing articles:
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer
Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 20, pp. 2446-2455
Open Access | Times Cited: 28
Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 20, pp. 2446-2455
Open Access | Times Cited: 28
Nectin-4-targeted immunoSPECT/CT imaging and photothermal therapy of triple-negative breast cancer
Fuqiang Shao, Zhidi Pan, Yu Long, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 40
Fuqiang Shao, Zhidi Pan, Yu Long, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 40
Nuclear Medicine and Molecular Imaging in Urothelial Cancer: Current Status and Future Directions
Sandra McDonald, K.G. Keane, Richard Gauci, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 232-232
Open Access | Times Cited: 1
Sandra McDonald, K.G. Keane, Richard Gauci, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 232-232
Open Access | Times Cited: 1
CAR-Based Immunotherapy of Solid Tumours—A Survey of the Emerging Targets
John Maher, David M. Davies
Cancers (2023) Vol. 15, Iss. 4, pp. 1171-1171
Open Access | Times Cited: 18
John Maher, David M. Davies
Cancers (2023) Vol. 15, Iss. 4, pp. 1171-1171
Open Access | Times Cited: 18
A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer
Yue Wu, Min Zhu, Baihe Sun, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Yue Wu, Min Zhu, Baihe Sun, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence
Mohammad Javad Khosravanian, Yousef Mirzaei, Ali Hussein Mer, et al.
Life Sciences (2024) Vol. 352, pp. 122910-122910
Closed Access | Times Cited: 7
Mohammad Javad Khosravanian, Yousef Mirzaei, Ali Hussein Mer, et al.
Life Sciences (2024) Vol. 352, pp. 122910-122910
Closed Access | Times Cited: 7
Nectins and Nectin-like molecules drive vascular development and barrier function
Doryssa Hermans, Carla Rodriguez-Mogeda, Hannelore Kemps, et al.
Angiogenesis (2023) Vol. 26, Iss. 3, pp. 349-362
Closed Access | Times Cited: 15
Doryssa Hermans, Carla Rodriguez-Mogeda, Hannelore Kemps, et al.
Angiogenesis (2023) Vol. 26, Iss. 3, pp. 349-362
Closed Access | Times Cited: 15
Mechanism of 5-fluorouracil induced resistance and role of piperine and curcumin as chemo-sensitizers in colon cancer
Dorothy Bhattacharjya, N Sivalingam
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 5
Dorothy Bhattacharjya, N Sivalingam
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 5
Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies
Jun He, Xianghua Zeng, Chunmei Wang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 5
Jun He, Xianghua Zeng, Chunmei Wang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 5
Exploring membranous NECTIN‐4 expression patterns and enfortumab vedotin response in prostate cancer
Richard Weiten, Marit Bernhardt, Max Niemann, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 14
Open Access | Times Cited: 4
Richard Weiten, Marit Bernhardt, Max Niemann, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 14
Open Access | Times Cited: 4
The Icarian flight of antibody-drug conjugates: target selection amidst complexity and tackling adverse impacts
Han Liu, Hongye Zeng, Xiaojing Qin, et al.
Protein & Cell (2025)
Open Access
Han Liu, Hongye Zeng, Xiaojing Qin, et al.
Protein & Cell (2025)
Open Access
5′-UTR G-Quadruplex-Mediated Translation Regulation in Eukaryotes: Current Understanding and Methodological Challenges
Polina N. Kamzeeva, Vera A. Alferova, Vladimir A. Korshun, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1187-1187
Open Access
Polina N. Kamzeeva, Vera A. Alferova, Vladimir A. Korshun, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1187-1187
Open Access
Pilot Study of Nectin-4–Targeted PET Imaging Agent68Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human
Li Sun, Yuyun Sun, Ke Zuo, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.269024-jnumed.124.269024
Closed Access
Li Sun, Yuyun Sun, Ke Zuo, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.269024-jnumed.124.269024
Closed Access
Unlocking the mechanisms underlying the activity of pembrolizumab plus enfortumab vedotin in patients with urothelial carcinoma
Matteo Santoni, Alessandro Rizzo, Francesco Massari
Expert Opinion on Investigational Drugs (2025)
Closed Access
Matteo Santoni, Alessandro Rizzo, Francesco Massari
Expert Opinion on Investigational Drugs (2025)
Closed Access
Decoding the Nectin Interactome: Implications for Brain Development, Plasticity, and Neurological Disorders
Shreyash Santosh Yadav, Krishnamoorthy Srinivasan, Shyam Sunder Sharma, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Shreyash Santosh Yadav, Krishnamoorthy Srinivasan, Shyam Sunder Sharma, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Theranostic Implications of Nectin-4 Oncoprotein in Gynecologic Cancers: A Review
Olivia Hooks, Yash Nagpal, Justin T Childers, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155913-155913
Closed Access
Olivia Hooks, Yash Nagpal, Justin T Childers, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155913-155913
Closed Access
Toxicities and management strategies of emerging antibody–drug conjugates in breast cancer
Sora Kang, Sung‐Bae Kim
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Sora Kang, Sung‐Bae Kim
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
9MW2821, a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase Ⅰ/Ⅱ study
Jian Zhang, Ruifeng Liu, Shixuan Wang, et al.
Annals of Oncology (2025)
Closed Access
Jian Zhang, Ruifeng Liu, Shixuan Wang, et al.
Annals of Oncology (2025)
Closed Access
Emerging strategy for the treatment of urothelial carcinoma: Advances in antibody-drug conjugates combination therapy
Xiangyun You, Chunming Zhu, Puguang Yu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116152-116152
Open Access | Times Cited: 3
Xiangyun You, Chunming Zhu, Puguang Yu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116152-116152
Open Access | Times Cited: 3
NECTIN4‐targeted antibody–drug conjugate is a potential therapeutic option for extramammary Paget disease
Yuka Tanaka, Takamichi Ito, Maho Murata, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 3
Open Access | Times Cited: 3
Yuka Tanaka, Takamichi Ito, Maho Murata, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 3
Open Access | Times Cited: 3
Genomic and Transcriptomic Significance of Multiple Primary Lung Cancers Detected by Next-Generation Sequencing in Clinical Settings
Meihong Yao, Hu Chen, Zui Chen, et al.
Carcinogenesis (2024) Vol. 45, Iss. 6, pp. 387-398
Closed Access | Times Cited: 3
Meihong Yao, Hu Chen, Zui Chen, et al.
Carcinogenesis (2024) Vol. 45, Iss. 6, pp. 387-398
Closed Access | Times Cited: 3
Current Landscape of Antibody-Drug Conjugate Development in Head and Neck Cancer
Jong Chul Park, Donghoon Shin
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 3
Jong Chul Park, Donghoon Shin
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 3
Emerging Targets and Therapeutics in Immuno-Oncology: Insights from Landscape Analysis
Kavita A. Iyer, Julian Ivanov, Rumiana Tenchov, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 8519-8544
Open Access | Times Cited: 2
Kavita A. Iyer, Julian Ivanov, Rumiana Tenchov, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 8519-8544
Open Access | Times Cited: 2
Effects of PEGylation on Imaging Contrast of 68Ga-Labeled Bicyclic Peptide PET Probes Targeting Nectin-4
Qiang Wan, Hongmei Yuan, Ping Cai, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4430-4440
Closed Access | Times Cited: 2
Qiang Wan, Hongmei Yuan, Ping Cai, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4430-4440
Closed Access | Times Cited: 2
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review
Emanuele Crupi, Tiago Costa de Pádua, Laura Marandino, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 2
Emanuele Crupi, Tiago Costa de Pádua, Laura Marandino, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 2
